PCBL's Q2FY26 profitability was below our expectations. Carbon black sales declined 3% YoY, primarily due to an 11% YoY drop in realizations driven by weak demand amid global uncertainty. Domestic volumes increased by 10% YoY, while export volumes grew by 6% YoY. The Consolidated EBITDA margin contracted 450bps YoY to 12.3%, reflecting margin compression in both the carbon black and Aquapharm segments, largely due to pricing pressure on falling crude prices. EBITDA/t for carbon black segment fell 24% QoQ to Rs13,489 amid high input tariffs imposed by US. Consequently, we revise our...